Kymriah 600000000 Cells (Tisagenlecleucel SUSPENSION) 600000000 CELLS

KYMRIAH 600000000 CELLS is a specialized suspension used in advanced medical treatments. This intravenous therapy is designed for specific therapeutic applications, offering a targeted approach to certain health conditions.

Strength

600000000 CELLS

Pack Size

10 TO 50 ML

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KYMRIAH 600000000 CELLS is primarily used in the treatment of certain types of cancer. This therapy involves the use of genetically modified cells to target and combat cancer cells within the body. The suspension is administered intravenously and is intended for use under strict medical supervision.

Side Effects

Patients may experience a range of effects when using KYMRIAH 600000000 CELLS. Common effects can include fatigue, fever, and general discomfort. These effects are typically monitored and managed by healthcare professionals to ensure patient safety and comfort.

Precautions & Warnings

Handling KYMRIAH 600000000 CELLS requires careful attention to storage and administration guidelines. It is crucial to follow the prescribed protocols to minimize the risk of adverse effects. Patients should be closely monitored for any signs of complications during and after treatment.

Avoid Interactions

KYMRIAH 600000000 CELLS may interact with other medications or treatments. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain other substances should be avoided to ensure the safety and effectiveness of the therapy.

Frequently Asked Questions

KYMRIAH 600000000 CELLS is used in the treatment of certain types of cancer, utilizing genetically modified cells to target cancer cells.

KYMRIAH 600000000 CELLS is administered intravenously, typically under strict medical supervision.

Common effects may include fatigue, fever, and general discomfort, which are usually monitored and managed by healthcare professionals.

Yes, it is important to follow storage and administration guidelines carefully and to be monitored for any signs of complications.

Yes, it may interact with other medications, so it is important to inform healthcare providers about all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.